Valid Ghana · FDA Ghana

LUZE TABLETS

Lutein/Zeaxanthin

FDA/SD.245-112281 Lutein/Zeaxanthin 6mg/1mg INN generic

What it does

Lutein is a natural pigment found in various foods that supports eye health.

Commonly used for: eye health, macular degeneration, cataracts

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.245-112281
Registration date
2024-12-02
Expiry date
2030-01-01
Status
Valid
Active ingredient
Lutein/Zeaxanthin
Dosage form
Lutein/Zeaxanthin
Strength
6mg/1mg
Pack size
-
Therapeutic class
-
RxNorm RxCUI
11359
Manufacturer / MAH
Corona Remedies
Country of origin
-

Source: Food and Drugs Authority · fetched 2026-04-18 08:33:01 · updated 2026-10-20 04:00:11

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About lutein

Lutein is a natural pigment found in various foods that supports eye health.

What it treats

  • eye health
  • macular degeneration
  • cataracts

How it works

Lutein helps protect the eyes from harmful light and oxidative damage.

Who it's for

People looking to maintain or improve their eye health.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About zeaxanthin

Zeaxanthin is a natural pigment found in various fruits and vegetables that may help support eye health.

What it treats

  • supports eye health
  • may help prevent age-related macular degeneration (AMD)

How it works

Zeaxanthin filters harmful blue light and helps protect the retina from damage.

Who it's for

This supplement is suitable for individuals looking to maintain or improve their eye health, especially older adults.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: lutein

BNF-referenced

Lutein is a xanthophyll carotenoid with significant antioxidant properties that plays a crucial role in eye health. It is naturally found in high concentrations in the macula of the retina, where it filters harmful blue light and protects against oxidative damage. Lutein is believed to contribute to the prevention of age-related eye diseases, including Age-related Macular Degeneration (AMD) and cataracts, by quenching reactive oxygen species and reducing oxidative stress.

Indications

  • Age-related Macular Degeneration (AMD)
  • Cataracts
  • Ocular health protection
  • Antioxidant support

Dosage

Children: Refer to BNF for Children for specific dosage guidance as it may vary based on formulation and clinical indication.

Adults: Refer to BNF for specific dosage guidance as it may vary based on formulation and clinical indication.

Mechanism of action

Lutein exhibits antioxidant activity by reacting with active oxygen species, leading to the production of biologically active degradation products. It inhibits the peroxidation of membrane phospholipids and reduces lipofuscin formation, which are key contributors to oxidative stress. Additionally, lutein filters blue light and near-ultraviolet radiation, providing protective effects in the retina due to its ability to scavenge reactive oxygen species. It also enhances the expression of connexin-43, facilitating gap junctional communication and offering potential protection against cancer.

Pharmacodynamics

Lutein is concentrated in the macula of the retina, where it exerts protective effects against oxidative stress and high-energy light. Its presence is linked to a decreased risk of developing eye diseases such as Age-related Macular Degeneration (AMD). Studies indicate that higher macular pigment density is associated with a reduced risk of these conditions, highlighting lutein's role in maintaining eye health.

Pharmacokinetics

Lutein is absorbed in the gastrointestinal tract and its bioavailability can be influenced by the presence of dietary fats. It is transported in the bloodstream primarily via lipoproteins and is distributed to various tissues, with a significant accumulation in the retina and lenses of the eyes. The elimination half-life and metabolic pathways are not well characterized, but lutein is known to be more stable against degradation by pro-oxidants compared to other carotenoids.

Pregnancy

Lutein is generally considered safe during pregnancy, but consult a healthcare provider for individual assessment.

Breast-feeding

Lutein is likely safe during breastfeeding, but it is advisable to consult a healthcare provider.

Storage

Store in a cool, dry place away from light.

Formulations

  • Supplement capsules
  • Softgel formulations
  • Powdered forms for mixing

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: zeaxanthin

BNF-referenced

Zeaxanthin is a carotenoid with the molecular formula C40H56O2, primarily found in green leafy vegetables and some fruits. It is known for its antioxidant properties and plays a crucial role in eye health, particularly in the prevention of age-related macular degeneration.

Indications

  • Age-related macular degeneration
  • Eye health supplementation
  • Antioxidant support

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Zeaxanthin acts as a light filter in the retina, protecting the eyes from harmful high-energy light waves like ultraviolet rays. It is believed to neutralize free radicals and reduce oxidative stress, which can contribute to various ocular diseases. Additionally, zeaxanthin is involved in the carotenoid biosynthesis pathways, including its conversion from violaxanthin and its role in various biosynthetic processes.

Pharmacodynamics

Zeaxanthin exhibits antioxidant activity, which helps protect cells from oxidative damage. It is selectively deposited in the macula of the eye, where it contributes to visual acuity and may prevent photochemical damage caused by light exposure. Its presence in the retina aids in filtering blue light and supports overall retinal health.

Pharmacokinetics

Zeaxanthin is absorbed in the gastrointestinal tract after dietary intake, with peak plasma concentrations occurring several hours post-ingestion. It is transported in the bloodstream bound to lipoproteins, and its bioavailability can vary based on dietary fat presence. The half-life of zeaxanthin in the body is not well established but is believed to be several days, as it is stored in the retina and other tissues.

Pregnancy

There is insufficient data on the safety of zeaxanthin during pregnancy. Consult a healthcare provider for advice.

Breast-feeding

Limited data is available on the excretion of zeaxanthin in human milk. Consult a healthcare provider for guidance.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

  • Dietary supplements
  • Ophthalmic preparations

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: lutein

PubChem CID 5281243

Molecular formula: C40H56O2

Mechanism of action

Xanthophylls have antioxidant activity and react with active oxygen species, producing biologically active degradation products. They also can inhibit peroxidation of membrane phospholipids and reduce lipofuscin formation, both of which contribute to their antioxidant properties. Lutein is naturally present in the macula of the human retina. It filters out potentially phototoxic blue light and near-ultraviolet radiation from the macula. The protective effect is due in part, to the reactive oxygen species quenching ability of these carotenoids. Lutein is more stable to decomposition by pro-oxidants than are other carotenoids such as beta-carotene and lycopene. Lutein is abundant in the region surrounding the fovea, and lutein is the predominant pigment at the outermost periphery of the macula. Zeaxanthin, which is fully conjugated (lutein is not), may offer somewhat better protection than lutein against phototoxic damage caused by blue and near-ultraviolet light radiation. Lutein is one of only two carotenoids that have been identified in the human lens, may be protective against age-related increases in lens density and cataract formation. Again, the possible protection afforded by lutein may be accounted for, in part, by its reactive oxygen species scavenging abilities. Carotenoids also provide protection from cancer. One of the mechanisms of this is by increasing the expression of the protein connexin-43, thereby stimulating gap junctional communication and preventing unrestrained cell proliferation.

Pharmacodynamics

Lutein was found to be present in a concentrated area of the macula, a small area of the retina responsible for central vision. The hypothesis for the natural concentration is that lutein helps protect from oxidative stress and high-energy light. Several studies show that an increase in macula pigmentation decreases the risk for eye diseases such as Age-related Macular Degeneration (AMD).

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.